Basic Science and Pathogenesis
Transactive DNA-binding protein 43 (TDP-43) proteinopathy is associated with neurodegeneration, including LATE and linked to cognitive deterioration. While some research suggests a higher prevalence of TDP-43 in women, no differences have been identified among racial groups. Nonetheless, the influen...
Gespeichert in:
Veröffentlicht in: | Alzheimer's & dementia 2024-12, Vol.20 Suppl 1, p.e090471 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Transactive DNA-binding protein 43 (TDP-43) proteinopathy is associated with neurodegeneration, including LATE and linked to cognitive deterioration. While some research suggests a higher prevalence of TDP-43 in women, no differences have been identified among racial groups. Nonetheless, the influence of gender on cognition within the context of TDP-43 remains uncertain. Our objective was to investigate gender and racial distinctions in the relationship between TDP-43 presence and cognitive function.
Cross-sectional study in a population-based sample of 1,164 Brazilians from the Biobank for Aging Studies of the University of Sao Paulo Medical School. We used linear regression to evaluate the association of progressive LATE stages with cognitive abilities evaluated by Clinical Dementia Rating Sum of Boxes (CDR-SOB). Models were adjusted for sociodemographic (age at death, sex, education, and race), clinical variables (hypertension, diabetes, heart disease, stroke, alcohol consumption, smoking, and body mass index) and neuropathological lesions (Braak staging, CERAD, Lewy body diseases pathology, lacunar infarcts, hyaline arteriolosclerosis and cerebral angiopathy amyloid). Additionally, we investigated the interaction of TDP-43 pathology with race (white and black) and sex on CDR-SOB.
Sociodemographic and clinical variables were different between the participants with and without LATE (Table 1). Adjusted analysis, accounting for sociodemographic and clinical factors, revealed a significant association between the presence of LATE and impaired cognitive abilities (β = 5.13, 95% CI = 3.63;6.33, p |
---|---|
ISSN: | 1552-5279 1552-5279 |
DOI: | 10.1002/alz.090471 |